KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to 0.32%.

  • Biolife Solutions' EBITDA Margin rose 16400.0% to 0.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.03%, marking a year-over-year decrease of 317800.0%. This contributed to the annual value of 8.67% for FY2024, which is 222300.0% up from last year.
  • As of Q3 2025, Biolife Solutions' EBITDA Margin stood at 0.32%, which was up 16400.0% from 65.47% recorded in Q2 2025.
  • Over the past 5 years, Biolife Solutions' EBITDA Margin peaked at 0.32% during Q3 2025, and registered a low of 218.96% during Q4 2022.
  • Moreover, its 5-year median value for EBITDA Margin was 28.81% (2022), whereas its average is 52.12%.
  • In the last 5 years, Biolife Solutions' EBITDA Margin plummeted by -1742900bps in 2022 and then skyrocketed by 1747600bps in 2024.
  • Quarter analysis of 5 years shows Biolife Solutions' EBITDA Margin stood at 49.5% in 2021, then tumbled by -342bps to 218.96% in 2022, then rose by 16bps to 184.05% in 2023, then soared by 95bps to 9.29% in 2024, then surged by 97bps to 0.32% in 2025.
  • Its EBITDA Margin was 0.32% in Q3 2025, compared to 65.47% in Q2 2025 and 5.09% in Q1 2025.